The development of a new selective medium for the isolation of Brucella abortus from contaminated sources.
D000362:Agar; D000666:Amphotericin B / Q000494:pharmacology; D000818:Animals; D001414:Bacitracin / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects; D002003:Brucella abortus / Q000187:drug effects / Q000302:isolation & purification*; D002417:Cattle; D003091:Colistin / Q000494:pharmacology; D003470:Culture Media; D003513:Cycloheximide / Q000494:pharmacology; D004058:Diffusion; D007201:Indicator Dilution Techniques; D008892:Milk / Q000382:microbiology; D009761:Nystatin / Q000494:pharmacology; D011113:Polymyxins / Q000494:pharmacology; D014640:Vancomycin / Q000494:pharmacology
D003470:Culture Media; D011113:Polymyxins; D009761:Nystatin; D001414:Bacitracin; D014640:Vancomycin; D000666:Amphotericin B; D000362:Agar; D003513:Cycloheximide; D003091:Colistin